feed,title,long_url,short_url
Benzinga,"Halozyme, Chugai Ink $185M ENHANZE Technology Licensing Pact",https://benzinga.com/general/biotech/22/03/26276647/halozyme-chugai-ink-185m-enhanze-technology-licensing-pact,https://bit.ly/3qywqou
Benzinga,Ping Shares Jump On Rating Upgrade By Stifel,https://benzinga.com/analyst-ratings/analyst-color/22/03/26277177/ping-shares-jump-on-rating-upgrade-by-stifel,https://bit.ly/3iAx9Bg
Benzinga,FDA Rejects Lilly's Sintilimab/Chemo Combo Therapy In First-Line Lung Cancer Setting,https://benzinga.com/general/biotech/22/03/26276424/fda-rejects-lillys-sintilimabchemo-combo-therapy-in-first-line-lung-cancer-setting,https://bit.ly/37ZPzJB
